๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone

โœ Scribed by Tsunemine, Hiroko; Akasaka, Hiroshi; Sakane, Emiko Ishikawa; Ito, Kiminari; Kodaka, Taiichi; Takahashi, Takayuki


Book ID
125378983
Publisher
Carden Jennings Publishing
Year
2013
Tongue
English
Weight
313 KB
Volume
99
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Gemtuzumab ozogamicin in the treatment o
โœ Francis Giles; Elihu Estey; Susan O'Brien ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 484 KB ๐Ÿ‘ 2 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized antiโ€CD33 antibody (hP67.6) linked to Nโ€acetylโ€ฮณ calicheamicin 1,2โ€dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration